Oral Stimulants

搜索文档
Doseology Appoints Patrick W. Sills as Strategic Go-to-Market Advisor
Thenewswire· 2025-07-17 19:00
Kelowna, BC – July 17, 2025 – TheNewswire – Doseology Sciences Inc. (CSE: MOOD | PINK: DOSEF | FSE: VU70) (“Doseology” or the “Company”), an innovator in precision-formulated oral stimulants, is pleased to announce the appointment of Patrick W. Sills as Strategic Go-to-Market Advisor.Mr. Sills is an experienced commercial strategist with over 15 years of leadership in the nicotine and functional CPG sectors. His career includes senior roles with Philip Morris International and Fontem Ventures B.V., where h ...